Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
55.25
+0.88 (1.62%)
At close: May 15, 2025, 4:00 PM
54.85
-0.40 (-0.72%)
After-hours: May 15, 2025, 4:05 PM EDT
Utah Medical Products Revenue
Utah Medical Products had revenue of $9.71M in the quarter ending March 31, 2025, a decrease of -14.37%. This brings the company's revenue in the last twelve months to $39.27M, down -19.92% year-over-year. In the year 2024, Utah Medical Products had annual revenue of $40.90M, down -18.56%.
Revenue (ttm)
$39.27M
Revenue Growth
-19.92%
P/S Ratio
4.78
Revenue / Employee
$235,168
Employees
167
Market Cap
181.27M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 40.90M | -9.32M | -18.56% |
Dec 31, 2023 | 50.22M | -2.06M | -3.93% |
Dec 31, 2022 | 52.28M | 3.23M | 6.58% |
Dec 31, 2021 | 49.05M | 6.88M | 16.30% |
Dec 31, 2020 | 42.18M | -4.73M | -10.08% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
UTMD News
- 9 days ago - Utah Medical Products, Inc. Announces Quarterly Dividend - Accesswire
- 9 days ago - Stock Picks From Seeking Alpha's April 2025 New Analysts - Seeking Alpha
- 16 days ago - Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2025 - Accesswire
- 4 weeks ago - Utah Medical Products: Quietly Profitable--A Deep Value Gem Hiding In The Open - Seeking Alpha
- 3 months ago - UTMD Reports Year 2024 and Fourth Quarter Financial Performance - Accesswire
- 5 months ago - Utah Medical Products: Favorably Skewed Risk/Reward Profile - Seeking Alpha
- 6 months ago - Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend - Accesswire
- 7 months ago - UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024 - Accesswire